Renal Cancers Completed Phase 2 Trials for Bortezomib (DB00188)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00017329PS-341 in Treating Patients With Metastatic Kidney CancerTreatment
NCT00025376PS-341 in Treating Patients With Metastatic Kidney CancerTreatment
NCT00276614Bortezomib in Treating Patients With Metastatic Kidney CancerTreatment